Europe Pharmaceutical Blister Packaging market
Trend & Growth Rate Report
Europe Pharmaceutical Blister Packaging market was valued at US$ 7,989.0 Mn in 2020 and it is
expected to reach at US$ 12,949.8 Mn by 2027, growing at a CAGR of 7.5% over the forecast period.
Blister packages are very beneficial for shielding goods due to some external factors, including
moistness & pollution for long duration. Also, blister packaging is a light-sensitive material used
against UV rays and it is portable in nature and can protect drugs over a long shelf life. Blister This is
improved type of packaging compared with conventional packaging that includes product integrity,
production, and tamper proof, compact prospect of accidental misuse, and patient compliance.
Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Europe-
In the report, Europe Pharmaceutical Blister Packaging market has been analyzed
through a segmental perspective. The market segmentation allows a deeper
understanding of the market hotspots.
Europe Pharmaceutical Blister Packaging Market Share Analysis by Technology
Blister packaging is the most preferred packaging solution in healthcare industry. Blister packaging of
products reduces the possibility of product contamination & protects healthcare products from light,
moisture, gas, and temperature. This is fuelling the demand for blister packaging in healthcare end-
use sector. The market is segmented on the basis of technology into thermoforming and cold forming.
Thermoforming is defined as process where rigid plastics, closed-cell foams, and other specialty
materials are heated to a pliable forming temperature, formed to a specific shape in a mold, &
trimmed to create a usable product.
Thermoforming holds the major revenue share of the overall pharmaceutical blister packaging market.
Thermoforming technology is preferred over cold forming technology for blister packaging & requires